BioNTech CEO Uğur Şahin featured on Bloomberg's latest billionaires list
Uğur Şahin, the CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce one of the world’s first Covid-19 vaccines, is the only person of Turkish origin featured on the latest Bloomberg Billionaires Index.
The Turkish-German oncologist and immunologist’s net worth stands at $7.8 billion ranking him as 305th, according to the index, which tracks the net worth of the 500 wealthiest people on the planet.
Together with Pfizer, BioNTech developed an mRNA vaccine against COVID-19 that was the first to be authorized in the European Union and the United States in December of 2020.
The 56-year-old scientist, who was born in Turkey and grew up in Germany, owns about 17 percent of BioNTech, which went public on the Nasdaq in October 2019.
With the development of the COVID-19 vaccine, BioNTech’s stock has risen by 900 percent since its 2019 IPO and the company was valued at $37 billion in 2021, Forbes reported. BioNTech expects to generate $11.5 billion of revenue under deals for the vaccine that have already been struck, it said.
Şahin and his wife and chief medical officer of BioNTech, Özlem Türeci, cofounded the company in 2008, with the backing of German billionaire brothers Thomas and Andreas Struengmann.
Şahin and Türeci were named the People of the Year by British daily, the Financial Times in 2020.